Nav: Home

Preterm births more common in mothers who are cancer survivors

March 23, 2017

CHAPEL HILL -- For young women facing a new cancer diagnosis, fertility preservation can be an important consideration in treatment planning. Now a University of North Carolina Lineberger Comprehensive Cancer Center-led study has identified potential risks for mothers who are cancer survivors -- risks for their newborns' health.

In a study published in the journal JAMA Oncology, researchers report that women diagnosed and treated for cancer during their childbearing years more commonly gave birth prematurely, and to babies whose weights were below normal. Cancer survivors also had a slightly higher rate of cesarean section deliveries.

"We found that women were more likely to deliver preterm if they've been treated for cancer overall, with greater risks for women who had chemotherapy," said the study's senior author Hazel B. Nichols, PhD, a UNC Lineberger member and assistant professor in the UNC Gillings School of Global Public Health. "While we believe these findings are something women should be aware of, we still have a lot of work to do to understand why this risk is becoming apparent, and whether or not the children who are born preterm to these women go on to develop any health concerns."

Research has shown that 60 percent of female adolescent and young adult survivors want the possibility of having children, researchers report. Yet few studies have focused on the impact of cancer treatment on children born to women diagnosed and treated for cancer during their childbearing years.

Nichols and her colleagues developed their study by linking cancer diagnosis and birth certificate data for patients diagnosed with cancer between the ages of 15 and 39 in North Carolina from 2000 to 2013. They studied health outcomes for the first child women had after their cancer diagnosis, including information from more than 2,500 babies born to mothers who were cancer survivors.

"One of the things that's exciting about this work is we identified thousands of women who went on to have a child after they were diagnosed and treated for cancer," Nichols said. "We know that cancer treatment can have an impact on fertility, and it's only after puberty that some of the options exist to either freeze eggs or freeze embryos, or take other steps to protect fertility. So this is a time period when it's important to counsel women on what their reproductive risks are for cancer therapy, or what they can expect in the future."

The researchers found that cancer survivors had a greater risk for delivering a baby before 37 weeks. Cancer survivors also had a higher risk of having babies of a low birth weight and there was a small increase in cesarean deliveries.

Among cancer survivors, 13 percent of cancer survivors had a preterm birth (born before 37 weeks), compared to 9 percent of women who did not have cancer. Nichols said those are small differences, but preterm birth is a risk that women should be aware of. Babies born earlier than 37 weeks have a higher risk of complications. However, Nichols cautioned that that not all babies born preterm experience these complications.

"It's a risk factor; it doesn't mean that someone who is born preterm is going to develop future health problems, but children who don't spend as long in utero can have a higher incidence of breathing problems or infections," she said. "This is something for women and their providers to be aware of when a woman is reviewing her prenatal care, or talking about her medical history with her provider."

When the researchers broke the data down by cancer diagnosis, they found that risk for preterm birth for breast cancer survivors was nearly two times that of women who had not had cancer. They found a 60 percent higher risk of preterm birth in women with Hodgkin lymphoma, an increased risk of approximately two times in women with non-Hodgkin lymphoma, and a risk that was nearly three times higher for women with gynecologic cancers.

They also found the risk of preterm birth and low birth weight was highest for women diagnosed with cancer while pregnant. Nichols said women diagnosed during pregnancy may be delivering early in order to start their cancer treatment, but that may not be the only factor. They also detected an increased risk in women diagnosed with cancer before the start of pregnancy.

A review of prevalence of preterm birth by treatment type found women who had chemotherapy were more likely to have preterm deliveries, and, to a lesser extent, to have cesarean deliveries. Nichols said this is an area of possible future research for the group.

"We'd like to get better information about the types of chemotherapy women receive," she said. "Chemotherapy is a very broad category, and the agents have very different effects on the body. In the future, we'd like to get more detailed information on the types of drugs that were involved in treatment."

Nichols said the study contained positive findings as well as exposed risks for survivors.

"These are risks that are important to understand, but also should be considered in light of the fact that these women went on to start their families, or complete their families," she said. "So that's a very positive event."
-end-
In addition to Nichols, other authors include Chelsea Anderson, MPH, Stephanie Engel, PhD, Jennifer E. Mersereau, MD, Kristin Z. Black, PhD, William A. Wood, MD, and Carey K. Anders, MD.

This research was supported by the National Center for Advancing Translational Sciences, and a Faculty Development Award from the University of North Carolina Office of the Provost.

UNC Lineberger Comprehensive Cancer Center

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
More Cancer News and Cancer Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab